Bellerophon Therapeutics, Inc. Soared
Fri, Dec 17, 2021 at 05:30 PM
Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) rocketted at $3.19, representing a gain of 34.6%. The stock got featured on our News Catalysts scanner on Fri, Dec 17, 2021 at 08:35 AM in the 'BIOTECH' category. From Thu, Dec 02, 2021, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Jun 23, 2021 at $5.95 with a volume of 5M+, and its share price has been moving sideways in recent weeks.
About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)
Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.
Top 10 Gainers:
- SPRB (SPRB:NASDAQ), 102.82%
- Genfit SA (GNFT:NASDAQ), 54.24%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 34.6%
- IREN (IREN:NASDAQ), 26.25%
- GLTO (GLTO:NASDAQ), 22.61%
- ARQQ (ARQQ:NASDAQ), 21.98%
- SNCE (SNCE:NASDAQ), 20.14%
- INZY (INZY:NASDAQ), 19.87%
- EVTL (EVTL:NYSE), 19.44%
- Net 1 UEPS Technologies, Inc. (UEPS:NASDAQ), 19.39%